CJC-1295 (With DAC)

CJC-1295 (With DAC)

$75.00

CJC-1295 (With DAC) is an investigational research peptide studied for extended-duration GHRH signaling and growth hormone–axis dynamics. The DAC component is used in research to explore longer persistence and steadier pathway activation versus short-acting variants. For laboratory research use only. Not for human or veterinary use.Protocols are commonly approached low and slow (conservative titration) for clean observations.

19 in stock

Categories: , Tags: , ,

CJC-1295 (With DAC) 5mg — Extended-Action Research Peptide (Laboratory Use Only)

CJC-1295 (With DAC) is a widely used research chemical selected for laboratory studies investigating growth hormone–axis signaling over longer time horizons. “DAC” (Drug Affinity Complex) is utilized in research design to explore prolonged circulation time and more sustained engagement of GHRH-related pathways compared with non-DAC formulations.

Research Use Only: Not intended for human consumption. Not for diagnostic, therapeutic, or clinical use. Not for veterinary use.

Why researchers choose it

  • Studied for GHRH receptor signaling linked to GH-axis dynamics

  • The DAC component supports research into extended-duration signaling and time-course effects

  • Useful for protocols tracking longer-window biomarker trends (model-dependent, e.g., IGF-1)

  • Often selected when researchers want fewer intervention points while observing sustained pathway activity in controlled models

How it works (Research focus)

In research contexts, CJC-1295 (With DAC) is investigated for its ability to:

  • Maintain prolonged GHRH-pathway engagement in study models

  • Support extended monitoring of downstream biomarker patterns and response curves

  • Provide a consistent tool for comparing short- vs long-acting GH-axis research strategies

Related products